BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Law ML, Cohen H, Martin AA, Angulski ABB, Metzger JM. Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies. J Clin Med 2020;9:E520. [PMID: 32075145 DOI: 10.3390/jcm9020520] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Chou OH, Tse YL, Ng KM, Tse HF. Application of Patient-Specific iPSCs for Modelling and Treatment of X-Linked Cardiomyopathies. Int J Mol Sci 2021;22:8132. [PMID: 34360897 DOI: 10.3390/ijms22158132] [Reference Citation Analysis]
2 Sullivan RT, Lam NT, Haberman M, Beatka MJ, Afzal MZ, Lawlor MW, Strande JL. Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model. BMC Cardiovasc Disord 2021;21:302. [PMID: 34130633 DOI: 10.1186/s12872-021-02112-4] [Reference Citation Analysis]
3 Wiggs MP, Beaudry AG, Law ML. Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors. Cells 2022;11:1931. [PMID: 35741060 DOI: 10.3390/cells11121931] [Reference Citation Analysis]
4 Vu Hong A, Sanson M, Richard I, Israeli D. A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy. Eur J Transl Myol 2021;31. [PMID: 34533019 DOI: 10.4081/ejtm.2021.10012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yao S, Chen Z, Yu Y, Zhang N, Jiang H, Zhang G, Zhang Z, Zhang B. Current Pharmacological Strategies for Duchenne Muscular Dystrophy. Front Cell Dev Biol 2021;9:689533. [PMID: 34490244 DOI: 10.3389/fcell.2021.689533] [Reference Citation Analysis]
6 de Souza F, Bittar Braune C, Dos Santos Nucera APC. Duchenne muscular dystrophy: an overview to the cardiologist. Expert Rev Cardiovasc Ther 2020;18:867-72. [PMID: 32985912 DOI: 10.1080/14779072.2020.1828065] [Reference Citation Analysis]
7 Starosta A, Konieczny P. Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy. Cell Mol Life Sci 2021;78:4867-91. [PMID: 33825942 DOI: 10.1007/s00018-021-03821-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mareedu S, Pachon R, Thilagavathi J, Fefelova N, Balakrishnan R, Niranjan N, Xie LH, Babu GJ. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice. Am J Physiol Heart Circ Physiol 2021;320:H200-10. [PMID: 33216625 DOI: 10.1152/ajpheart.00601.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ohlendieck K, Swandulla D. Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy. Pflugers Arch 2021;473:1813-39. [PMID: 34553265 DOI: 10.1007/s00424-021-02623-1] [Reference Citation Analysis]
10 Atmanli A, Chai AC, Cui M, Wang Z, Nishiyama T, Bassel-Duby R, Olson EN. Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy. Circ Res 2021;129:602-16. [PMID: 34372664 DOI: 10.1161/CIRCRESAHA.121.319579] [Reference Citation Analysis]
11 Choi A, Park SE, Jeong JB, Choi SJ, Oh SY, Ryu GH, Lee J, Jeon HB, Chang JW. Anti-Fibrotic Effect of Human Wharton's Jelly-Derived Mesenchymal Stem Cells on Skeletal Muscle Cells, Mediated by Secretion of MMP-1. Int J Mol Sci 2020;21:E6269. [PMID: 32872523 DOI: 10.3390/ijms21176269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Zabłocka B, Górecki DC, Zabłocki K. Disrupted Calcium Homeostasis in Duchenne Muscular Dystrophy: A Common Mechanism behind Diverse Consequences. Int J Mol Sci 2021;22:11040. [PMID: 34681707 DOI: 10.3390/ijms222011040] [Reference Citation Analysis]
13 Gilbert G, Kadur Nagaraju C, Duelen R, Amoni M, Bobin P, Eschenhagen T, Roderick HL, Sampaolesi M, Sipido KR. Incomplete Assembly of the Dystrophin-Associated Protein Complex in 2D and 3D-Cultured Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Front Cell Dev Biol 2021;9:737840. [PMID: 34805146 DOI: 10.3389/fcell.2021.737840] [Reference Citation Analysis]
14 Florczyk-Soluch U, Polak K, Dulak J. The multifaceted view of heart problem in Duchenne muscular dystrophy. Cell Mol Life Sci 2021;78:5447-68. [PMID: 34091693 DOI: 10.1007/s00018-021-03862-2] [Reference Citation Analysis]
15 Raccah BH, Biton B, Amir O, Gotsman I, Nahman D, Matok I. Anti-Remodeling Cardiac Therapy in Patients With Duchenne Muscular Dystrophy, Meta-Analysis Study. Front Pharmacol 2022;12:769896. [DOI: 10.3389/fphar.2021.769896] [Reference Citation Analysis]
16 Lee A, Moon J, Yu J, Kho C. MicroRNAs in Dystrophinopathy. IJMS 2022;23:7785. [DOI: 10.3390/ijms23147785] [Reference Citation Analysis]
17 Angelini G, Mura G, Messina G. Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies. Exp Cell Res 2022;410:112968. [PMID: 34883113 DOI: 10.1016/j.yexcr.2021.112968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Péladeau C, Jasmin BJ. Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy. RNA Biol 2021;18:1238-51. [PMID: 33164678 DOI: 10.1080/15476286.2020.1847894] [Reference Citation Analysis]
19 Rehman MYA, Briedé JJ, van Herwijnen M, Krauskopf J, Jennen DGJ, Malik RN, Kleinjans JCS. Integrating SNPs-based genetic risk factor with blood epigenomic response of differentially arsenic-exposed rural subjects reveals disease-associated signaling pathways. Environ Pollut 2022;292:118279. [PMID: 34619179 DOI: 10.1016/j.envpol.2021.118279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Merlo M, Cannatà A, Sinagra G. Dilated Cardiomyopathy: A Paradigm of Revolution in Medicine. J Clin Med 2020;9:E3385. [PMID: 33105590 DOI: 10.3390/jcm9113385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Marini V, Marino F, Aliberti F, Giarratana N, Pozzo E, Duelen R, Cortés Calabuig Á, La Rovere R, Vervliet T, Torella D, Bultynck G, Sampaolesi M, Chai YC. Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression. Front Cell Dev Biol 2022;10:878311. [DOI: 10.3389/fcell.2022.878311] [Reference Citation Analysis]
22 Bourque K, Hawey C, Jiang A, Mazarura GR, Hébert TE. Biosensor-based profiling to track cellular signalling in patient-derived models of dilated cardiomyopathy. Cell Signal 2022;91:110239. [PMID: 34990783 DOI: 10.1016/j.cellsig.2021.110239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]